Resolian is a leading global Contract Research Organization (CRO) that offers specialised services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetics (DMPK), and GMP CMC analytical and materials science. The company boasts a team of over 500 experts operating across the United States, United Kingdom, and Australia, dedicated to supporting the pharmaceutical industry in various stages of drug development and compliance.

Services include:
– Accelerated Stability Studies
– ADMET
– Analytical Services
– Animal Health
– Anti-Counterfeiting Technology
– Assay Development
– Bioanalytical Services
– Biomarker Research
– Biosimilars
– Chemical Analysis
– Raw Materials
– Chemistry (CMC)
– Combinatorial
– Medicinal
– Chiral Separations
– R&D
– Chromatography
– Clinical Trials
– Manufacturing
– Consulting
– Contaminant Analysis
– Contract Research (CRO)
– Dosage Form Development
– Drug Development
– Contract Development
– Excipients
– Testing
– Feasibility Studies
– Flavours
– Forced Degradation Studies
– Process Development
– Formulation Development
– Controlled Release
– Gene Therapy & Testing Protocols
– Imaging
– In Vitro Testing
– Lead Optimization
– Lot Release Testing
– Mass Spectrometry
– Materials Analysis
– Measuring & Testing Technology
– Clinical Studies
– Micro FT-IR Analysis
– Microscopic Analysis
– Nutritional Support Analysis
– Packaging
– Anti-Counterfeiting
– Design & Testing
– Parenterals
– Particle Characterization
– Particle Size Analysis
– Particle Size Classification
– Pharmacokinetics
– Pharmacology
– Photostability
– Physical Testing
– Preclinical Testing
– Preclinical Testing Formulations
– Preformulation
– Process Characterization
– Quality QA/QC
– R&D Services
– Raw Materials Analysis
– Screening
– Classifying
– Stability Studies
– Stability
– ICH
– Target Profiling
– Technology Transfer
– Thermogravimetric Analysis
– Trace Metal Analysis
– ICP
– UV-VIS Spectrophotometer Analysis
– Validation
– Vitamin Analysis
– Wet Chemical Analysis
– X-Ray Crystallography
– X-Ray Powder Diffraction

Resolian remains committed to delivering high-quality research and analytical services tailored to clients’ needs, ensuring compliance and innovation in drug development. For more information, please visit resolian.com.